Global Biopharmaceuticals Packaging Market: Market Outlook
Biopharmaceuticals are medicinal drugs that are manufactured by using biotechnology. They are mainly proteins (antibodies), nucleic acids (DNA, RNA) which are commonly used for in vivo or therapeutic purposes. Biopharmaceutical packaging plays a very important role in maintaining the product quality and characteristics of the drugs.
Biopharmaceuticals are very sensitive to the temperature and the environment to they are being exposed, thereby biopharmaceuticals packaging act as a shield to the biological or biopharmaceutical products by temperature regulation and without causing any damage to the product. Biopharmaceuticals are used over many untreatable conditions on which there are negligible chances of working of the conventional drug or medicine.
Furthermore, the biopharmaceutical manufacturers are seeking new methods for promoting and protecting their products, meeting new regulations, and increasing patient compliance which will uplift the demand for the biopharmaceuticals packaging market. Thereby, owing to the above factors, the biopharmaceuticals packaging market is projected to gain a certain demand in the coming years.
What are the Key Trends Impacting Growth of the Biopharmaceuticals Packaging Market?
The new evolving diseases on which the medicinal drug is not that effective with combatting the disease, even after conducting several clinical studies or phase trials, biosimilar/antibodies/cytokines extracted from the living or biological source can trigger the demand for biopharmaceuticals market, thereby increasing the demand for the biopharmaceuticals packaging market. Also, the launch of biosimilar drugs in the next five years will lead to significant growth in the biopharmaceuticals packaging market.
The ground-breaking development in biopharma research for the treatment of autoimmune diseases and diseases like cancer is also expected to create a positive impact on the biopharmaceuticals packaging market.
New Technologies Growing Attention for Biopharmaceuticals Packaging
Blow-fill-seal (BFS), a packaging technology is growing attention for the biopharmaceutical products, in which the plastic vials or any other form of container firstly is formed, filled, and sealed in a continuous process. This method allows product manufacturing in a sterile and controlled environment. BFS is mostly used for biopharmaceuticals as it not only offers low-cost packaging but also sterility assurance with minimum human intervention. Also, this method is suitable for biological products which are temperature sensitive and cannot withstand high temperature for terminal sterilization.
How is the Demand for Biosimilar Uplifting the Biopharmaceuticals Packaging Market?
A biosimilar is a biological medicinal product that is manufactured using living organisms which is similar to another approved biological medicine. Biosimilar is used to treat a variety of diseases such as cancer, cystic fibrosis, and other autoimmune disorders. Biosimilar is manufactured using a complex process and is very sensitive to the outer environment. After conducting several clinical trials, FDA approves the drug after studying its effect and then if found effective, can be used for the treatment of the diseases.
The Food & Drug Administration (FDA) approved the first biosimilar product for marketing in the United States in March 2015. After that, recognizing the biosimilars' important role in 2018, the FDA also launched the Biosimilars Action Plan to help encourage additional competition.
Therefore, the underlined efficacy of the biosimilar with the FDA approval is forecasted to boost the biopharmaceuticals packaging market.
Avail customized purchase options for your needs
What are the Key Challenges that may Restrain Growth of the Biopharmaceuticals Packaging Market?
The cost of the biopharmaceutical packaging is high owing to the cost of manufacturing the biopharmaceutical product, long process durations which are costlier to run, the costly raw materials, and also a team of highly skilled experts. Also, the biopharmaceutical products are temperature-sensitive and need to be transported through controlled environmental conditions which are very challenging.
Key players such as
- Merck KGaA
- LOG Pharma Packaging
- W.L Gore & Associates Inc.
- West Pharmaceutical Services Inc.
- Pacific Vial Manufacturing
- Piramal Glass Private Limited
- Gerresheimer AG
- Stevanato Group
- Shandong Pharmaceutical Glass Co
- Chongqing Zhengchuan Pharmaceutical Packaging Co.
are actively involved in offering vegan protein for different applications.
An Adaptive Approach to Modern-day Research Needs
What strategies are the Key Players adopting for Increasing their Market Share in the Biopharmaceuticals Packaging Market?
The manufacturers involved in the production of the biopharmaceutical packaging containers on a larger capacity. The research and innovation are also conducted to launch innovative packaging for biopharmaceutical products. Also, some of the key players are acquiring small pharmaceutical companies to increase their production capacity.
- In June 2020, Stevanato Group, SCHOTT, and Gerresheimer confirmed the readiness to support future Covid-19 vaccines by ensuring an ample supply of pharmaceutical containers for the vaccine. Each of the three companies manufactured billions of type-1 borosilicate glass vials, which is the most widely available and proven material used to store and deliver vaccines around the world.
- In March 2019, W.L. Gore & Associates, Inc. launched The Gore Sta-Pure Flexible Freeze Container that maintains package integrity after freezing at -86 degree Celsius (-123 degree Fahrenheit) and minimizes the product loss due to package failure considering its durable design.
Why is the U.S. a Big Market for Biopharmaceuticals Packaging Market?
The ongoing research and technological advancements in the field of science and high healthcare spending are the major factors that are driving the growth of the Biopharmaceuticals Packaging Market in the U.S. Also, the presence of the majority of pharmaceutical companies in the U.S. is bolstering the growth of the biopharmaceuticals packaging market.
Interested to Procure The Data
How has the COVID-19 pandemic impacted the Biopharmaceuticals Packaging Market?
The COVID-19 pandemic has affected positively the Biopharmaceuticals Packaging Market. During this pandemic, there was an immense requirement from the hospitals for plasma for the treatment for the coronavirus (SARS-COV). This created an opportunity for the pharma companies to manufacture biopharmaceutical packaging for the transfer of plasma which thereby boosted the demand for the biopharmaceuticals packaging market.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
Key Segments of Biopharmaceuticals Packaging Market Covered in the Report
Based on material type, the Biopharmaceuticals Packaging Market has been segmented as
Based on product type, the Biopharmaceuticals Packaging Market has been segmented as
- Pre-filled syringes
Based on application, the Biopharmaceuticals Packaging Market has been segmented as
- Monoclonal Antibodies
- Gene therapies
- Products derived from recombinant DNA
- Others (Tissues, etc.)
Based on the region, the Biopharmaceuticals Packaging Market has been segmented as
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.